Seelos Therapeutics (FRA:NXE) Days Sales Outstanding : 0.00 (As of Jun. 2024)

View and export this data going back to . Start your Free Trial

What is Seelos Therapeutics Days Sales Outstanding?

Seelos Therapeutics's average Accounts Receivable for the three months ended in Jun. 2024 was €0.89 Mil. Seelos Therapeutics's Revenue for the three months ended in Jun. 2024 was €0.00 Mil.

The historical rank and industry rank for Seelos Therapeutics's Days Sales Outstanding or its related term are showing as below:

During the past 13 years, Seelos Therapeutics's highest Days Sales Outstanding was 45.14. The lowest was 14.53. And the median was 29.84.

FRA:NXE's Days Sales Outstanding is not ranked ^*
in the Biotechnology industry.
Industry Median: 72.59
* Ranked among companies with meaningful Days Sales Outstanding only.

Seelos Therapeutics's Days Sales Outstanding stayed the same from Jun. 2023 (0.00) to Jun. 2024 (0.00).

Seelos Therapeutics Days Sales Outstanding Historical Data

The historical data trend for Seelos Therapeutics's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Seelos Therapeutics Days Sales Outstanding Chart

Seelos Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

Seelos Therapeutics Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Days Sales Outstanding	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Seelos Therapeutics's Days Sales Outstanding

For the Biotechnology subindustry, Seelos Therapeutics's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Seelos Therapeutics's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Seelos Therapeutics's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Seelos Therapeutics's Days Sales Outstanding falls into.

Seelos Therapeutics Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Seelos Therapeutics's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0	+	0.7)	/	1 )	/	0	*	365
=	0.7					/	0	*	365
=	N/A

Seelos Therapeutics's Days Sales Outstanding for the quarter that ended in Jun. 2024 is calculated as:

	Days Sales Outstanding (Q: Jun. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Mar. 2024 )	+	Accounts Receivable (A: Jun. 2024 ))	/	count )	/	Revenue (A: Jun. 2024 )	*	Days in Period
=	( (0.891	+	0)	/	1 )	/	0	*	365 / 4
=	0.891					/	0	*	365 / 4
=	N/A

Seelos Therapeutics (FRA:NXE) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Seelos Therapeutics Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Seelos Therapeutics's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Seelos Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Seelos Therapeutics Inc (FRA:NXE) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

SEEL:USA

Address

300 Park Avenue, 2nd Floor, New York, NY, USA, 10022

Website

https://www.seelostherapeutics.com

Seelos Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing products that address unmet needs in Central Nervous System (CNS) disorders and other rare disorders. Its product pipeline includes SLS-002, SLS-005, SLS-004, SLS-007, and SLS-009.